文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

Empty-RT:空膀胱前列腺立体定向放疗的2期试验

Empty-RT: A Phase 2 Trial of Prostate Stereotactic Body Radiation Therapy With an Empty Bladder Approach.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2026-07-31

该2期试验评估前列腺癌患者空膀胱状态下行SBRT的可行性和剂量学安全性,118例可评估患者中急性≥2级泌尿不良事件发生率为28.1%(90% CI 21.2-35.8),达到非劣效阈值,提示空膀胱SBRT急性安全性与标准充盈膀胱方案相当。

要点

  • 空膀胱前列腺SBRT的急性≥2级泌尿AE为28.1%,满足非劣效界值。
  • 模拟定位膀胱体积较大与≥2级泌尿AE风险升高相关(OR 1.02)。

核心结论

  • 空膀胱前列腺SBRT在剂量学上可行且可重复,急性安全性与标准充盈膀胱方案相当。
  • 若经更大规模研究验证,可能成为省时且对患者友好的常规前列腺SBRT替代方案。

研究设计与样本

  • 2期试验纳入组织学确诊前列腺癌并计划行SBRT(前列腺35-36.25 Gy/5次,±盆腔淋巴结25 Gy,隔日或每周一次)的患者。
  • 患者于定位CT扫描及每次SBRT分次前立即排尿,利用机载锥形束CT评估分次间膀胱体积变异性。
  • 主要终点为急性≥2级泌尿不良事件发生率(CTCAE v5.0),非劣效界值为+10%,参照PRIME随机试验32%的参考率。
  • 139例患者完成空膀胱模拟扫描,其中118例满足计划约束并接受空膀胱治疗,构成安全性可评估队列。

主要发现

  • 118例可评估患者中,急性≥2级泌尿AE发生率为28.1%(90% CI,21.2-35.8),达到非劣效阈值。
  • 3级AE罕见:泌尿系1例(0.9%),胃肠道0例;2级胃肠道AE发生率为7.9%。
  • 模拟定位时空膀胱中位体积为77 cm3(IQR,59-110),个体患者分次间膀胱体积变异为18%。

关键数值与推荐

  • 模拟膀胱体积≤10 cm3被认为不适合空膀胱工作流程(n=7),另有14例未满足计划约束。
  • 主要终点非劣效界值为+10%,参照PRIME随机试验32%的参考率。
  • 急性≥2级泌尿AE发生率28.1%(90% CI,21.2-35.8)满足非劣效阈值。

临床怎么用

  • 在前列腺SBRT中可采用空膀胱工作流程,治疗前立即排尿,并以锥形束CT评估膀胱体积变异。
  • 模拟定位时膀胱体积较大者≥2级泌尿AE风险升高,需关注其计划约束与安全性。
  • 每周一次SBRT可能与较低胃肠道AE相关,但需更大规模研究验证。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the feasibility and dosimetric safety of prostate stereotactic radiation therapy (SBRT) with an empty bladder approach. METHODS: Eligible patients had histologically confirmed prostate cancer and were planned for stereotactic body radiation therapy (SBRT) (35-36.25 Gy/5# to prostate ± 25 Gy to pelvic nodes, alternate days or once-weekly). Participants voided immediately before the planning computed tomography scan and each SBRT fraction. Interfraction bladder volume variability was evaluated with onboard cone beam computed tomography. The primary endpoint was the rate of acute urinary grade 2+ adverse event (Common Terminology Criteria for Adverse Events version 5.0), with a noninferiority margin of +10% compared with a 32% reference rate from the PRIME randomized trial (NCT03561961) using similar planning constraints. RESULTS: Simulation scans were acquired with an empty bladder for 139 patients, of which planning constraints were achieved for 118 patients (simulation bladder volume ≤ 10 cm3 deemed unsuitable for empty bladder workflow, n = 7; planning constraints not met, n = 14). These 118 patients were treated with empty bladder and constituted the trial cohort evaluable for safety. Median simulation empty bladder volume was 77 cm3 (IQR, 59-110). Interfraction bladder volume variation for individual patients was 18%. Grade ≥2 urinary adverse events (AE) occurred in 28.1% (90% CI, 21.2-35.8), meeting the noninferiority threshold. Grade 3 AE were rare (urinary n = 1, 0.9%; gastrointestinal [GI] = 0), and 7.9% had grade 2 GI AE. Higher bladder volume at simulation was associated with a higher risk of grade 2+ urinary AE (odds ratio, 1.02; 95% CI, 1.01-1.03; P = .002). Once-weekly SBRT was associated with lower GI AE (0% vs 12.9%; P = .03) but not urinary AE. CONCLUSION: Prostate SBRT delivered with an empty bladder was observed to be dosimetrically feasible and reproducible, with acute safety comparable with standard full bladder protocols. If validated in larger studies, it may offer a time-efficient and patient-friendly alternative in routine prostate SBRT practice.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Murthy V, Gulati S, Ghosh S, et al. Empty-RT: A Phase 2 Trial of Prostate Stereotactic Body Radiation Therapy With an Empty Bladder Approach. Int J Radiat Oncol Biol Phys. 2026. PMID: 42537851. doi:10.1016/j.ijrobp.2026.07.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。